Newborn affected by maternal use of other drugs of addiction
Billable / specificHCC V28 137
P04.49 is a billable, specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes in FY2027.
Inclusion terms
Includes (from P04)
- conditions that have their origin in the fetal or perinatal period (before birth through the first 28 days after birth) even if morbidity occurs later
- nonteratogenic effects of substances transmitted via placenta
- Note: Codes from this chapter are for use on newborn records only, never on maternal records
- Note: These codes are for use when the listed maternal conditions are specified as the cause of confirmed morbidity or potential morbidity which have their origin in the perinatal period (before birth through the first 28 days after birth).
Excludes2
Not included here — may be reported together when both conditions exist.
- newborn affected by maternal anesthesia and analgesia (P04.0)
- withdrawal symptoms from maternal use of drugs of addiction (P96.1)
- congenital malformations, deformations and chromosomal abnormalities (Q00-Q99) (from P04)
- endocrine, nutritional and metabolic diseases (E00-E88) (from P04)
- injury, poisoning and certain other consequences of external causes (S00-T88) (from P04)
- neoplasms (C00-D49) (from P04)
- tetanus neonatorum (A33) (from P04)
- congenital malformations (Q00-Q99) (from P04)
- encounter for observation of newborn for suspected diseases and conditions ruled out (Z05.-) (from P04)
- neonatal jaundice from excessive hemolysis due to drugs or toxins transmitted from mother (P58.4) (from P04)
- newborn in contact with and (suspected) exposures hazardous to health not transmitted via placenta or breast milk (Z77.-) (from P04)
Code first
Sequence the underlying condition first.
- any current condition in newborn, if applicable (from P04)
Also known as
- Newborn, affected by, drugs of addiction, specified drug NEC
- Newborn, affected by, maternal, drugsNEC
- Newborn, affected by, methamphetamine
Parent code
- P04.4Newborn affected by maternal use of drugs of addictionHeader